XML 14 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Statements of Consolidated Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]        
Net sales $ 840,937 $ 830,797 $ 2,340,031 $ 2,520,576
Cost of sales 593,712 594,045 1,667,491 1,791,130
Gross profit 247,225 236,752 672,540 729,446
Selling, distribution and administrative expense, including depreciation 172,758 183,702 498,659 556,485
Impairment expense 0 131,000 49,528 131,000
Operating income (loss) 74,467 (77,950) 124,353 41,961
Interest expense, net 7,608 8,805 22,919 28,447
Other income, net (1,657) (1,428) (1,746) (1,643)
Income (loss) before income taxes 68,516 (85,327) 103,180 15,157
Income tax expense (benefit) 12,453 (2,550) 17,667 21,104
Net income (loss) $ 56,063 $ (82,777) $ 85,513 $ (5,947)
Net income (loss) per share - basic $ 1.44 $ (2.14) $ 2.21 $ (0.15)
Net income (loss) per share - diluted $ 1.42 $ (2.14) $ 2.18 $ (0.15)
Weighted average common shares outstanding for basic computation 38,835 38,682 38,779 38,647
Dilutive effect of potential common shares 577 0 482 0
Weighted average common shares outstanding for diluted computation 39,412 38,682 39,261 38,647